Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Immunotherapy for prostate cancer
Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
Natural killer cells license dendritic cell cross-presentation of B lymphoma cell–associated antigens
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells
Vaccine strategies to treat lymphoproliferative disorders
Harnessing the immune system against human glioma
Thermal regulation of lymphocyte trafficking: hot spots of the immune response
Virus-based therapies for colon cancer
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
Immunological treatment of liver tumors
Prostate cancer immunology: biology, therapeutics, and challenges
Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins
Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity
Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer